The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...
A government-wide hiring freeze and halt to funding of travel, meetings and communications have officials at the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback